Moderate Obstructive Sleep Apnea (OSA) is a common sleep disorder marked by repeated pauses or shallow breathing during sleep, typically 15 to 30 times per hour. These disruptions reduce sleep quality and can silently impact overall health.
Unlike occasional snoring, moderate OSA causes frequent awakenings, daytime fatigue, and raises the risk of serious issues like hypertension…
Important Study Shows Vivos Technology to be a Safe and Highly Effective, Non-Surgical Alternative to Surgical Removal of Tonsils and Adenoids in Children
LITTLETON, Colo., June 26, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leader in proprietary, non-invasive treatments for obstructive sleep apnea (OSA), today announced that the European Journal of…
Mild obstructive sleep apnea, or Mild OSA, is a condition that many people overlook. It happens when your breathing stops for a short time while you sleep. So, what is mild OSA?
Mild OSA, or mild obstructive sleep apnea, occurs when someone experiences 5 to 14 breathing interruptions per hour during sleep. It can lead to…
Transaction brings OSA diagnostic revenue to Vivos, plus Vivos’ highly effective OSA treatment options to thousands of potential patients in the greater Las Vegas area
Transaction also completes Vivos’ business model pivot to target high patient volume centers and higher margin revenues
Over $11 million in new financing secured by Vivos, including a senior secured…
Obstructive Sleep Apnea (OSA) is a chronic disorder marked by repeated interruptions in breathing during sleep, resulting in fragmented sleep and increasing the risk of serious long-term health issues. If left untreated, it can increase the risk of heart disease, diabetes, and even cognitive decline. Fortunately, there are several effective treatments available that can dramatically…
Year-over-year product revenue increased 8%, and year-over-year operating expenses decreased 5% as Vivos sets the stage for its Sleep Center of Nevada acquisition and continued advancement of its new marketing and distribution model
Management to Host Conference Call today at 5:00 pm ET
LITTLETON, Colo., May 15, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the…
Call Scheduled for Thursday, May 15, 2025 at 5:00 pm ET
May 14, 2025 09:15 ET | Source: Vivos Therapeutics, Inc
LITTLETON, Colo., May 14, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments…
Obstructive Sleep Apnea (OSA) is a serious sleep disorder often overlooked during routine health checks. Interestingly, dental professionals are uniquely positioned to spot early warning signs during oral examinations.
If you're wondering, what are the dental clues that an adult has OSA? Understanding the subtle yet telling indicators in the mouth is crucial.
From tongue scalloping to…
By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas metro area
Acquisition expected to close later this quarter or in the third quarter
LITTLETON, Colo., April 16, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ:…
Why are misaligned teeth and jaw problems more common than ever? The answer goes far beyond genetics. Exploring the root cause of malocclusion uncovers surprising links to modern lifestyle habits, such as mouth breathing, poor posture, soft diets, and even screen time.
These subtle influences can disrupt natural jaw development and lead to long-term dental issues.…